1 DISCONTOOLS Update CWG Meeting, Rome, 30 th January 2015 Johannes Charlier, DISCONTOOLS Project...
-
Upload
hilary-boyd -
Category
Documents
-
view
213 -
download
0
Transcript of 1 DISCONTOOLS Update CWG Meeting, Rome, 30 th January 2015 Johannes Charlier, DISCONTOOLS Project...
1
DISCONTOOLS UpdateCWG Meeting, Rome, 30th January 2015
Johannes Charlier, DISCONTOOLS Project Manager
2
Content• Summary of activities in 2014
– Update progress 12 prioritised diseases– Communications– Website– Funding
• Activities planned in 2015
3
About DISCONTOOLS– Objective: Develop and maintain a database
containing critical information relevant to research needs in terms of knowledge gaps in relation to diagnostics, vaccines and pharmaceuticals.
– Output is Public website containing disease information for 52 infectious diseases with gap analysis and prioritisation model.
– Contributes to consensus across stakeholders concerning gaps and priorities to spend scarce research resources
4
12 diseases in focus (1)• Existing - AI, ASF, BTB, Campylobacter,
Cysticercosis, E. coli, FMD, Nematodes, ParaTB, PRRS, SIV
• New – PEDV• List determined by funders with offer to work on
Cysticercosis & PEDV
5
Expert group leadersDisease Expert group leader appointed
AI Timm Harder
ASF José Sanchez-Vizcaino
BT Margarida Correia Neves
Campylobacter Elina Lahti and Ingrid Hansson
Cysticercosis Pierre Dorny
E.coli Roberto La Ragione
FMD David Paton
Nematodes Jozef Vercruysse
ParaTB Herman Barkema
PEDV Hans Nauwynck
PRRS Hans Nauwynck
SIV Kristien Van Reeth
6
We developed online scoring system for gap analysis and prioritisation model
• Supports expert group leaders in collecting the information
• www.soscisurvey.de/DISCONTOOLS
7
Progress for the 12 diseases (1)Disease EG leader
agreed to do the work
EG established
Final documents when?
ASF yes yes Finished
ParaTB yes yes Expected February
Nematodes yes yes Expected February
FMD yes yes Expected February
E. coli yes yes Expected February-March
BTB yes yes Applied for funding FORMAS
Campylobacter yes yes Considering to apply for funding FORMAS (March 2015)
AI yes yes Expected 2015
8
Progress for the 12 diseases (2)Disease EG leader
agreed to do the work
EG established
Final documents when?
Cysticercosis yes Expected 2015
SIV yes Expected 2015
PRRSV yes Expected 2015
PEDV Yes Expected 2015
9
Communication materials• Poster was developed which can be used to
present DISCONTOOLS activities at several occasions
• Leaflet was developed explaining the current work of DISCONTOOLS (will be sent upon request)
• Scientific paper was not accepted by Prev. Vet. Med., now being considered for submission to Scientific and Technical Review of OIE
10
Conferences• DISCONTOOLS was presented at
– CYSTINET conference (4-5 Sep 2014, Antwerp), presentation
– PROVAXS seminar “Innovation in animal health through academia-industry partnerships” (4th Nov 2014, Ghent), poster
• Next planned conferences– SVEPM conference (March, Ghent), poster– WAAVP conference (August, Liverpool), poster
12
Website (2)• We are investing to make the database easier to
consult and include graphical display of prioritisation model.
13
Funding (1)• Countries having agreed to make a provision for 2015
Contributed in 2014 Made Provision for 2015
Austria Yes
Greece Yes
Ireland
Italy Yes
Switzerland Yes
The Netherlands Yes
UK – DEFRA
UK - BBSRC (meetings)
Sweden – FORMAS (meetings)
New: Spain
14
Funding (2)• Last funders meeting: Alex Morrow to explore
collaboration with OIE• In addition, we are considering a COST
application (Deadline 24st March 2015)
“Novel approaches for the prioritization of research on neglected and emerging
diseases of animals”
15
Work programme 2015 (1)
• Continue work with expert groups to update the D&Ps and scoring sheets
• Review and finalise the updated documents for approval by PMB and funders
• Organize PMB meeting• Load the approved information on the website
16
Work programme 2015 (2)
• Identify new diseases to initiate the updating procedure, liaising as much as possible with existing initiatives– Brucellosis (recent gap analysis performed, cfr.
Alex Morrow)– Leishmaniasis? (New Marie-Curie Training
Network)– Other ?
17
Conclusions
• Significant progress has been made for the 12 prioritised diseases, although for some diseases progress is more slow than anticipated (EG leaders “overbooked”).
• Need to identify new diseases to initiate the reviewing process, by preference liaising with existing initiatives.
• More results to be presented on a next Funder’s meeting in September?